CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessment
Dong Il Park, Tadakazu Hisamatsu, Minhu Chen, Siew Chien Ng, Choon Jin Ooi, Shu Chen Wei, Rupa Banerjee, Ida Normiha Hilmi, Yoon Tae Jeen, Dong Soo Han, Hyo Jong Kim, Zhihua Ran, Kaichun Wu, Jiaming Qian, Pin-Jin Hu, Katsuyoshi Matsuoka, Akira Andoh, Yasuo Suzuki, Kentaro Sugano, Mamoru Watanabe, Toshifumi Hibi, Amarender S. Puri, Suk-Kyun Yang
Intest Res. 2018;16(1):4-16.   Published online January 18, 2018
DOI: https://doi.org/10.5217/ir.2018.16.1.4

Excel Download

Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessment
Journal of Gastroenterology and Hepatology. 2017;33(1):20-29   Crossref logo
Link1 Link2

Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessment
Intestinal Research. 2018;16(1):4   Crossref logo
Link1 Link2 Link3

Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: Management
Journal of Gastroenterology and Hepatology. 2017;33(1):30-36   Crossref logo
Link1 Link2

Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: management
Intestinal Research. 2018;16(1):17   Crossref logo
Link1 Link2 Link3

Risk of Attenuated Live Vaccines-Induced Infections in Infants of Mothers Receiving Anti-Tumor Necrosis Factor Agents for Inflammatory Bowel Disease
Gastroenterology. 2016;151(6):1250   Crossref logo
Link1 Link2

Meta-Analysis of the Association Between Anti-Tumour Necrosis Factor Use and Lymphoma Risk in Patients With Inflammatory Bowel Disease: Methodological Considerations
Journal of Crohn's and Colitis. 2018;12(10):1257-1258   Crossref logo
Link1

Comment on ‘Meta-Analysis of the Association Between Anti-Tumour Necrosis Factor Use and Lymphoma Risk in Patients With Inflammatory Bowel Disease: Methodological Considerations’
Journal of Crohn's and Colitis. 2018;12(10):1259-1259   Crossref logo
Link1

The association of psoriasiform rash with anti-tumor necrosis factor (anti-TNF) therapy in inflammatory bowel disease: A single academic center case series
Journal of Crohn's and Colitis. 2014;8(6):480-488   Crossref logo
Link1 Link2 Link3

Risk of Serious Infection
Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. ;147-151   Crossref logo
Link1 Link2

Anti-tumor Necrosis Factor Agents and Tuberculosis in Inflammatory Bowel Disease
The Korean Journal of Gastroenterology. 2020;75(1):1   Crossref logo
Link1 Link2 Link3